Company Name: Vermillion, Inc.  

Vermillion, Inc. develops diagnostics used to detect and improve the treatment of gynecologic disease in women. The company’s OVA1® is a blood test that is designed to aid the physician in determining whether or not an ovarian mass is malignant before surgery is performed.      

Ticker Symbol: VRML (NASDAQ)

Company Website: www.vermillion.com

Social Media: Vermillion LinkedIn Page

Headquarters: Austin, TX